Literature DB >> 1960901

The effectiveness of a combination of etoposide/adriamycin/cisplatin (EAP) against inoperable gastric cancer--report of a histologically proven case.

H Tahara1, M Ogawa, Y Kido, H Shiozaki, I Ohashi, T Mori, M Sakurai.   

Abstract

We report herein, the histological observations taken at initial laparotomy from a 55 year old man with unresectable gastric cancer who responded almost completely to chemotherapy with Etoposide/Adriamycin/Cisplatin (EAP). The patient underwent a second operation after 2 cycles of EAP therapy and the stomach and adjacent lymph nodes were successfully resected. Histologic findings showed that cancer cells in the main tumor including the site of direct invasion had completely disappeared and been replaced by regenerated mucosa. The metastatic lymph node tumor was also partially killed, as indicated by a cluster of viable cancer cells which was divided by a strip of necrotic tissue. These findings led us to conclude that EAP therapy was remarkably effective for the patient.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1960901     DOI: 10.1007/bf02470971

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  7 in total

Review 1.  A review of chemotherapy in gastric cancer.

Authors:  R L Comis; S K Carter
Journal:  Cancer       Date:  1974-11       Impact factor: 6.860

2.  Cisplatin, doxorubicin, and 5-FU in combination for advanced gastric cancer.

Authors:  S E Vogl; P F Engstrom
Journal:  Cancer Treat Rep       Date:  1984-10

3.  Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.

Authors:  D P Kelsen; G B Magill; E Cheng; M Dukeman; P Sordillo; R Heelan; A Yagoda
Journal:  Cancer Treat Rep       Date:  1983-05

4.  Advanced inoperable stomach cancer: a pilot study with the combination etoposide, adriamycin and cisplatin.

Authors:  P Preusser; H Wilke; W Achterrath; B Neuhaus; L Balleisen; J Meyer; J Van de Loo
Journal:  Anticancer Res       Date:  1986 Sep-Oct       Impact factor: 2.480

5.  Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group.

Authors:  C G Moertel; P T Lavin
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

6.  Cisplatin. An active drug in the treatment of disseminated gastric cancer.

Authors:  L Leichman; B McDonald; A Dindogru; M Samson; V K Vaitkevicius
Journal:  Cancer       Date:  1984-01-01       Impact factor: 6.860

7.  Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer.

Authors:  D J Wagener; S H Yap; T Wobbes; J T Burghouts; F E van Dam; H F Hillen; G J Hoogendoorn; H Scheerder; S G van der Vegt
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.